Recruiting Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy NCT06957691 Conditions Adenocarcinoma, Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma, Androgen Deprivation Therapy, +40 more Locations Brigham and Women's Hospital — Boston, Massachusetts, United States View Trial Details
Completed Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis NCT00241111 Conditions Neoplasms, Prostate Cancer With Bone Metastasis Locations Not specified View Trial Details
